World Health Assembly delegates endorse action plan on antimicrobial resistance

26 May 2015
who-big

Delegates at the World Health Assembly have endorsed a global action plan to tackle antimicrobial resistance, including access to affordable vaccines.

The plan agreed at the World Health Assembly sets out five objectives: to improve awareness and understanding of antimicrobial resistance, to strengthen surveillance and research, to reduce the incidence of infection, to optimize the use of antimicrobial medicines, and to ensure sustainable investment in countering resistance. It urges member states to put the plan into action, adapting it to their national priorities and specific contexts and mobilizing additional resources for its implementation. By adopting the global plan, governments have committed to having in place by 2017 a national action plan on antimicrobial resistance that is aligned with the global action plan.

Immunization for the entire population

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical